Scolaris Content Display Scolaris Content Display

Drenaje retroperitoneal versus ningún drenaje después de la linfadenectomía pélvica para la prevención de formación de linfoquistes en pacientes con neoplasias ginecológicas

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Benedetti‐Panici 1997 {published data only}

Benedetti‐Panici P, Maneschi F, Butillo G, D'Andrea G, di Palumbo VS, Conte M, et al. A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies. Gynecologic Oncology 1997;65:478‐82. CENTRAL

Franchi 2007 {published data only}

Franchi M, Trimbos J, Zanaboni F, van der Velden J, Reed N, Coens C, et al. Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer‐Gynaecological Cancer Group (EORTC‐GCG) study in 234 patients. European Journal of Cancer 2007;43:1265‐8. CENTRAL

Lopes 1995 {published data only}

Lopes AB, Hall JR, Monaghan JM. Drainage following radical hysterectomy and pelvic lymphadenectomy: dogma or need?. Obstetrics and Gynecology 1995;86:960‐3. CENTRAL

Srisomboon 2002 {published data only}

Srisomboon J, Phongnarisorn C, Suprasert P, Cheewakriangkrai C, Siriaree S, Charoenkwan K. A prospective randomized study comparing retroperitoneal drainage with no drainage and no peritonization following radical hysterectomy and pelvic lymphadenectomy for invasive cervical cancer. Journal of Obstetrics and Gynaecology Research 2002;28(3):149‐53. CENTRAL

References to studies excluded from this review

Bafna 2001 {published data only}

Bafna UD, Umadevi K, Savitha M. Closed suction drainage versus no drainage following pelvic lymphadenectomy for gynecological malignancies. International Journal of Gynecological Cancer 2001;11:143‐6. CENTRAL

Franchi 1997 {published data only}

Franchi M, Ghezzi F, Zanaboni F, Scarabelli C, Beretta P, Donadello N. Nonclosure of peritoneum at radical abdominal hysterectomy and pelvic node dissection: a randomized study. Obstetrics and Gynecology 1997;90(4):622‐7. CENTRAL

Jensen 1993 {published data only}

Jensen JK, Lucci JA, DiSaia PJ, Manetta A, Berman ML. To drain or not to drain: a retrospective study of closed‐suction drainage following radical hysterectomy with pelvic lymphadenectomy. Gynecologic Oncology 1993;51(1):46‐9. CENTRAL

Morice 2001 {published data only}

Morice P, Lassau N, Pautier P, Haie‐Meder C, Lhomme C, Castaigne D. Retroperitoneal drainage after complete paraaortic lymphadenectomy for gynecologic cancer: a randomized trial. Obstetrics and Gynecology 2001;97(2):243‐7. CENTRAL

Orr 1986 {published data only}

Orr JW, Barter JF, Kilgore LC, Soong SJ, Shingleton HM, Hatch KD. Closed suction pelvic drainage after radical pelvic surgical procedures. American Journal of Obstetrics and Gynecology 1986;155(4):867‐71. CENTRAL

Patsner 1995 {published data only}

Patsner B. Closed‐suction drainage versus no drainage following radical abdominal hysterectomy with pelvic lymphadenectomy for stage IB cervical cancer. Gynecologic Oncology 1995;57:232‐4. CENTRAL

Patsner 1999 {published data only}

Patsner B. Routine retroperitoneal drainage is not required for uncomplicated pelvic lymphadenectomy for uterine cancer. European Journal of Gynaecological Oncology 1999;20(2):87‐9. CENTRAL

Yamamoto 2000 {published data only}

Yamamoto R, Saitoh T, Kusaka T, Todo Y, Takeda M, Okamoto K, et al. Prevention of lymphocyst formation following systematic lymphadenectomy. Japanese Journal of Clinical Oncology 2000;30(9):397‐400. CENTRAL

Conte 1990

Conte M, Benedetti‐Panici P, Guariglia L, Scambia G, Greggi S, Mancuso S. Pelvic lymphocele following radical para‐aortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management. Obstetrics and Gynecology 1990;76:268‐71.

Deeks 2008

Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from handbook.cochrane.org.

GRADE 2013

Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s), GRADE Working Group. GRADE Handbook. gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html (accessed 31 May 2017).

GRADEpro [Computer program]

GRADE Working Group, McMaster University. GRADEpro. Hamilton (ON): GRADE Working Group, McMaster University, 2014.

Higgins 2008

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from handbook.cochrane.org.

Ilancheran 1988

Ilancheran A, Monaghan J. Pelvic lymphocyst ‐ a 10‐year experience. Gynecologic Oncology 1988;29:333‐6.

Livingston 1980

Livingston W, Confer D, Smith R. Large lymphoceles resulting from retroperitoneal lymphadenectomy. Journal of Urology 1980;124:543‐6.

Maitland 1970

Maitland A, Mathieson A. Suction drainage. A study in wound healing. British Journal of Surgery 1970;57:193‐7.

Meader 2014

Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews 2014;3:82.

Petru 1989

Petru E, Tamussino K, Lahousen M, Winter R, Pickel H, Haas J. Pelvic and para‐aortic lymphocysts after radical surgery because of cervical and ovarian cancer. American Journal of Obstetrics and Gynecology 1989;161:937‐41.

RevMan 2012 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.

Symmond 1961

Symmond R, Pratt J. Prevention of fistulas and lymphocysts in radical hysterectomy. Preliminary report of a new technique. Obstetrics and Gynecology 1961;17:57‐64.

Symmond 1966

Symmond R. Morbidity and complications of radical hysterectomy with pelvic lymph node dissection. American Journal of Obstetrics and Gynecology 1966;94:663‐78.

Van Nagell 1976

Van Nagell J, Schweitz D. Surgical adjuncts in radical hysterectomy and pelvic lymphadenectomy. Surgery, Gynecology & Obstetrics 1976;143:735‐7.

References to other published versions of this review

Charoenkwan 2010

Charoenkwan K, Kietpeerakool C. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007387.pub2]

Charoenkwan 2014

Charoenkwan K, Kietpeerakool C. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD007387]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Benedetti‐Panici 1997

Methods

RCT. Randomisation was determined using a computer‐based method. The groups were comparable at entry. There was no exclusion after allocation and no withdrawal. Weekly abdominal and pelvic ultrasound was performed on 110 of 137 women to detect lymphocyst formation.

Participants

Women with FIGO stage I‐IV ovarian carcinoma (43 women), stage IB‐III cervical carcinoma (45 women), and stage I‐II endometrial carcinoma (49 women). The women underwent intensive surgical staging/tumour reductive surgery/second‐look laparotomy (ovarian carcinoma) or Piver type I/II radical hysterectomy (endometrial carcinoma) or Piver type III/IV radical hysterectomy (cervical carcinoma) plus bilateral pelvic or pelvic and para‐aortic lymphadenectomy.

Study setting: the Catholic University of Rome and the Hospital San Carlo di Nancy, Rome, Italy

Interventions

Women were randomised intraoperatively to the use of drains (68 women) or no drain (69 women). For those randomised to drains, 2 retroperitoneal low‐pressure closed‐suction drains were placed. For pelvic/para‐aortic lymphadenectomy, the first drain was placed at the insertion of the mesenteric artery down to the left external iliac artery, and the second drain at the level of the paracaval area from the point where the ovarian vein enters the cava down to the right external iliac artery. For pelvic lymphadenectomy, the cranial part of the drains was at the level of the ipsilateral common iliac vessels. The drains were removed when the loss was less than 50 mL in 24 hours.

Outcomes

There was a significant increase in complications (43% versus 22%) in the drain group, mainly related to lymphocyst. The hospital stay was shorter in the group not drained.

Notes

In all cases, the pelvic peritoneum and the peritoneum along the paracolic gutters were left open.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

It was stated that "Randomization was centralized and computer‐based."

Allocation concealment (selection bias)

Low risk

It was stated that "Randomization was centralized and computer‐based." The allocation concealment was probably adequate.

Blinding (performance bias and detection bias)
Lymphocyst formation

Low risk

Weekly ultrasound pelvic and abdominal examinations were performed; the ultrasound operator was unaware of the ongoing study.

Blinding (performance bias and detection bias)
Postoperative morbidities and recovery

Unclear risk

The blinding of participants, treatment providers, and outcome assessors was not documented.

Incomplete outcome data (attrition bias)
Short‐term lymphocyst formation

Low risk

It was stated that the weekly ultrasound examinations to detect lymphocyst formation were performed on 110 women operated on at the Catholic University (of 137 women in the study).

Selective reporting (reporting bias)

Unclear risk

The rate of asymptomatic lymphocyst formation was not specifically addressed.

Franchi 2007

Methods

Multicentre RCT (12 European cancer centres). Randomisation was determined using a computer‐based method. Stratification was performed per centre. The groups were comparable at entry. There was no exclusion after allocation and no withdrawal. Ultrasonography or CT scan was performed at 1 and 12 months postoperatively on all women to identify lymphocyst formation.

Participants

Women with FIGO stage IA1‐IIA cervical carcinoma (198 women), endometrial carcinoma (35 women), and vaginal carcinoma (1 woman). All had radical hysterectomy and bilateral pelvic lymphadenectomy.

Study setting: European cancer centres (the EORTC trial)

Interventions

Women were randomised following surgery to either pelvic drainage (117 women) or no drainage (117 women). For those randomised to drains, 2 passive or active suction drains were placed in the retroperitoneal fossa and inserted via the vagina or the abdominal route, according to the institution's policy. The drains were removed when the loss was less than 50 mL in 24 hours.

Outcomes

The study found no difference in the incidence of postoperative lymphocyst formation or postoperative complications between the 2 groups. The late (12 months) incidence of symptomatic lymphocysts was 5.9% in the drain group versus 0.9% in the no‐drain group (P = 0.06).

Notes

In all cases, the vaginal cuff was primarily closed and the pelvic peritoneum was left open.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Blinding (performance bias and detection bias)
Postoperative morbidities and recovery

Unclear risk

The blinding of participants, treatment providers, and outcome assessors was not documented.

Incomplete outcome data (attrition bias)
Short‐term lymphocyst formation

Low risk

Lopes 1995

Methods

RCT. Randomisation was determined using a random number table. The groups were comparable at entry. There was no exclusion after allocation and no withdrawal. An abdominal ultrasound scan was performed approximately 8 weeks after the surgery to identify any asymptomatic Iymphocysts.

Participants

Women with FIGO stage IA‐IIB cervical carcinoma (95 women) and stage IIB endometrial carcinoma (5 women). All had Piver type II radical hysterectomy and bilateral pelvic lymphadenectomy.

Study setting: Regional Department of Gynaecological Oncology, Gateshead, United Kingdom

Interventions

Women were randomised immediately before abdominal closure to the use of drains (51 women) or no drain (49 women). For those randomised to drains, 2 suction drains were inserted, 1 through each iliac fossa, and placed alongside the site of node dissection. The drains were usually removed when the loss was less than 100 mL in 24 hours.

Outcomes

The detection of lymphocysts by ultrasound and clinical examination in the drains group (15.6% and 5.9%, respectively) did not differ significantly from the group not drained (17.4% and 6.1%, respectively). Postoperative morbidity did not differ between the groups.

Notes

In each case, the vaginal cuff edge was oversewn, leaving the vaginal vault open, and the pelvis was not reperitonised.

Of the 100 women randomised, 8 defaulted their ultrasound scan: 5 were in the drained group and 3 were not. Of these 8, 2 (1 in each group) were assessed further; 1 had a magnetic resonance imaging scan and another had a laparotomy, both showing no evidence of lymphocysts.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomisation was determined using a random number table.

Allocation concealment (selection bias)

Low risk

The random allocation was done using numbered envelopes kept in the operating theatre. The allocation concealment was probably adequate, although the authors did not specifically mention whether or not the envelopes were sealed and opaque.

Blinding (performance bias and detection bias)
Lymphocyst formation

Unclear risk

An abdominal ultrasound scan was performed approximately 8 weeks after surgery to identify any asymptomatic lymphocysts. Also, the clinical detection of lymphocysts at subsequent review visits was documented. However, any attempt to blind outcome assessors was not mentioned.

Blinding (performance bias and detection bias)
Postoperative morbidities and recovery

Unclear risk

The blinding of participants, treatment providers, and outcome assessors was not documented.

Incomplete outcome data (attrition bias)
Short‐term lymphocyst formation

Low risk

It was stated that "Of the 100 women randomized, eight defaulted their ultrasound scan; five were in the drained group and three were not." Also, it was stated that "the scan was reported as unsatisfactory in one patient who had been drained."

Selective reporting (reporting bias)

Low risk

Srisomboon 2002

Methods

RCT. Randomisation was conducted by block randomisation. The groups were comparable at entry. There was no exclusion after allocation and no withdrawal. Transabdominal and transvaginal ultrasound were performed at 4, 8, and 12 weeks after surgery to detect lymphocyst formation.

Participants

Women with FIGO stage IA2‐IIA cervical carcinoma (100 women). All had Piver type II/III radical hysterectomy and bilateral pelvic lymphadenectomy.

Study setting: Chiang Mai University Hospital, Chiang Mai, Thailand

Interventions

Women were randomised immediately before abdominal closure to the use of drains with closure of pelvic peritoneum (52 women) or no drain with pelvic peritoneum left open (48 women). For those randomised to drains, 2 low‐pressure closed‐suction drains were placed along the side of node dissection and brought out extraperitoneally through the anterior abdominal wall lateral to the rectus muscle margins. The drains were removed when the loss was less than 50 mL in 24 hours.

Outcomes

Asymptomatic lymphocysts were sonographically detected at 4, 8, and 12 weeks postoperatively in 6.8%, 4.6%, and 7.7% of women, respectively, in the group not drained, whereas none were found in the drain group (P = 0.2). Postoperative morbidity did not differ significantly between the 2 groups.

Notes

The vaginal vault was primarily closed in all cases.

Of the 52 women in the drain group, 50, 46, and 44 women had ultrasound done at 4, 8, and 12 weeks after surgery, respectively, as scheduled. Of the 48 women in the no‐drain group, 44, 43, and 39 women underwent ultrasound examination at each scheduled visit.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

The method of block randomisation was used.

Allocation concealment (selection bias)

Low risk

The random allocation was done using sealed, numbered envelopes kept in the operating theatre.

Blinding (performance bias and detection bias)
Lymphocyst formation

Low risk

The operators of transabdominal and transvaginal ultrasound to detect lymphocyst formation were not aware of the group allocation.

Blinding (performance bias and detection bias)
Postoperative morbidities and recovery

High risk

The participants, treatment providers, and outcome assessors were not blinded.

Incomplete outcome data (attrition bias)
Short‐term lymphocyst formation

Low risk

The number of participants who had postoperative ultrasound performed at each visit as scheduled was reported. Accordingly, the number of missing cases was known.

Selective reporting (reporting bias)

Low risk

CT: computerised tomography
EORTC: European Organisation for Research and Treatment of Cancer
FIGO: International Federation of Gynecology and Obstetrics
RCT: randomised controlled trial

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Bafna 2001

Not an RCT

Franchi 1997

RCT comparing closure of pelvic and parietal peritoneum (with placement of a T‐shape suction drain through the vagina) to no peritoneal closure (but the vagina closed and 2 abdominal drains placed)

Jensen 1993

Not an RCT

Morice 2001

RCT comparing placement of a low‐pressure drain in the aortic area to no placement of para‐aortic drain after complete para‐aortic lymphadenectomy. However, most participants had suction drains placed in the pelvis.

Orr 1986

Not an RCT

Patsner 1995

Not an RCT

Patsner 1999

Not an RCT

Yamamoto 2000

Studied the effect of the procedure on preventing vaginal shortening on lymphocyst formation. A closed‐suction drain was placed in each paravesical space for all participants. Not an RCT

RCT: randomised controlled trial

Data and analyses

Open in table viewer
Comparison 1. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery Show forest plot

2

204

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.04, 13.35]

Analysis 1.1

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 1 Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 1 Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery.

2 Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery Show forest plot

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

3.25 [1.26, 8.37]

Analysis 1.2

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 2 Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 2 Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery.

3 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery Show forest plot

2

180

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.30, 1.71]

Analysis 1.3

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 3 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 3 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery.

4 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 12 weeks after surgery Show forest plot

1

83

Risk Ratio (M‐H, Fixed, 95% CI)

0.13 [0.01, 2.38]

Analysis 1.4

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 4 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 12 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 4 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 12 weeks after surgery.

5 Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery Show forest plot

1

232

Risk Ratio (M‐H, Fixed, 95% CI)

1.48 [0.89, 2.45]

Analysis 1.5

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 5 Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 5 Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery.

6 Long‐term lymphocyst formation: symptomatic at 12 months after surgery Show forest plot

1

232

Risk Ratio (M‐H, Fixed, 95% CI)

7.12 [0.89, 56.97]

Analysis 1.6

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 6 Long‐term lymphocyst formation: symptomatic at 12 months after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 6 Long‐term lymphocyst formation: symptomatic at 12 months after surgery.

7 Febrile morbidity Show forest plot

4

571

Risk Ratio (M‐H, Fixed, 95% CI)

1.76 [0.87, 3.55]

Analysis 1.7

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 7 Febrile morbidity.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 7 Febrile morbidity.

8 Pelvic infection Show forest plot

4

571

Risk Ratio (M‐H, Fixed, 95% CI)

0.42 [0.11, 1.62]

Analysis 1.8

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 8 Pelvic infection.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 8 Pelvic infection.

9 Wound infection Show forest plot

2

334

Risk Ratio (M‐H, Fixed, 95% CI)

0.29 [0.07, 1.18]

Analysis 1.9

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 9 Wound infection.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 9 Wound infection.

10 Wound dehiscence Show forest plot

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

0.99 [0.14, 6.89]

Analysis 1.10

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 10 Wound dehiscence.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 10 Wound dehiscence.

11 Fistula Show forest plot

3

471

Risk Ratio (M‐H, Fixed, 95% CI)

1.24 [0.34, 4.57]

Analysis 1.11

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 11 Fistula.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 11 Fistula.

12 Bowel obstruction Show forest plot

2

334

Risk Ratio (M‐H, Fixed, 95% CI)

0.2 [0.01, 4.12]

Analysis 1.12

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 12 Bowel obstruction.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 12 Bowel obstruction.

13 Leg oedema Show forest plot

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

2.71 [0.75, 9.77]

Analysis 1.13

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 13 Leg oedema.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 13 Leg oedema.

14 Deep venous thrombosis Show forest plot

2

371

Risk Ratio (M‐H, Fixed, 95% CI)

2.02 [0.38, 10.84]

Analysis 1.14

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 14 Deep venous thrombosis.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 14 Deep venous thrombosis.

15 Symptomatic ascites Show forest plot

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.12, 3.92]

Analysis 1.15

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 15 Symptomatic ascites.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 15 Symptomatic ascites.

16 Blood transfusion Show forest plot

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.68, 1.21]

Analysis 1.16

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 16 Blood transfusion.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 16 Blood transfusion.

17 Duration of surgery (minute) Show forest plot

1

100

Mean Difference (IV, Fixed, 95% CI)

4.20 [‐15.35, 23.75]

Analysis 1.17

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 17 Duration of surgery (minute).

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 17 Duration of surgery (minute).

18 Return of bowel sounds (day) Show forest plot

1

100

Mean Difference (IV, Fixed, 95% CI)

0.14 [‐0.11, 0.39]

Analysis 1.18

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 18 Return of bowel sounds (day).

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 18 Return of bowel sounds (day).

19 Hospital stay (day) Show forest plot

2

200

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐0.34, 0.74]

Analysis 1.19

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 19 Hospital stay (day).

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 19 Hospital stay (day).

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
Figuras y tablas -
Figure 1

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
Figuras y tablas -
Figure 2

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

PRISMA flow diagram.
Figuras y tablas -
Figure 3

PRISMA flow diagram.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 1 Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery.
Figuras y tablas -
Analysis 1.1

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 1 Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 2 Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery.
Figuras y tablas -
Analysis 1.2

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 2 Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 3 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery.
Figuras y tablas -
Analysis 1.3

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 3 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 4 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 12 weeks after surgery.
Figuras y tablas -
Analysis 1.4

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 4 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 12 weeks after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 5 Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery.
Figuras y tablas -
Analysis 1.5

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 5 Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 6 Long‐term lymphocyst formation: symptomatic at 12 months after surgery.
Figuras y tablas -
Analysis 1.6

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 6 Long‐term lymphocyst formation: symptomatic at 12 months after surgery.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 7 Febrile morbidity.
Figuras y tablas -
Analysis 1.7

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 7 Febrile morbidity.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 8 Pelvic infection.
Figuras y tablas -
Analysis 1.8

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 8 Pelvic infection.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 9 Wound infection.
Figuras y tablas -
Analysis 1.9

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 9 Wound infection.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 10 Wound dehiscence.
Figuras y tablas -
Analysis 1.10

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 10 Wound dehiscence.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 11 Fistula.
Figuras y tablas -
Analysis 1.11

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 11 Fistula.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 12 Bowel obstruction.
Figuras y tablas -
Analysis 1.12

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 12 Bowel obstruction.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 13 Leg oedema.
Figuras y tablas -
Analysis 1.13

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 13 Leg oedema.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 14 Deep venous thrombosis.
Figuras y tablas -
Analysis 1.14

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 14 Deep venous thrombosis.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 15 Symptomatic ascites.
Figuras y tablas -
Analysis 1.15

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 15 Symptomatic ascites.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 16 Blood transfusion.
Figuras y tablas -
Analysis 1.16

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 16 Blood transfusion.

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 17 Duration of surgery (minute).
Figuras y tablas -
Analysis 1.17

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 17 Duration of surgery (minute).

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 18 Return of bowel sounds (day).
Figuras y tablas -
Analysis 1.18

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 18 Return of bowel sounds (day).

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 19 Hospital stay (day).
Figuras y tablas -
Analysis 1.19

Comparison 1 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy, Outcome 19 Hospital stay (day).

Summary of findings for the main comparison. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for gynaecological malignancies

Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for gynaecological malignancies

Patient or population: Women with gynaecological malignancies
Settings: hospital
Intervention: retroperitoneal drainage versus no drainage after pelvic lymphadenectomy

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No. of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy

Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery

Study population

RR 0.76
(0.04 to 13.35)

204
(2 studies)

⊕⊕⊕
moderate1

172 per 1000

131 per 1000
(7 to 1000)

Medium‐risk population

161 per 1000

122 per 1000
(6 to 1000)

Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery

Study population

RR 3.25
(1.26 to 8.37)

237
(2 studies)

⊕⊕⊕⊕
high

43 per 1000

140 per 1000
(54 to 360)

Medium‐risk population

36 per 1000

117 per 1000
(45 to 301)

Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery

Study population

RR 0.72
(0.3 to 1.71)

180
(2 studies)

⊕⊕⊕⊕
high

112 per 1000

81 per 1000
(34 to 192)

Medium‐risk population

110 per 1000

79 per 1000
(33 to 188)

Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery

Study population

RR 1.48
(0.89 to 2.45)

232
(1 study)

⊕⊕⊕⊕
high

171 per 1000

253 per 1000
(152 to 419)

Medium‐risk population

171 per 1000

253 per 1000
(152 to 419)

Long‐term lymphocyst formation: symptomatic at 12 months after surgery

Study population

RR 7.12
(0.89 to 56.97)

232
(1 study)

⊕⊕⊕⊕
low1,2

9 per 1000

64 per 1000
(8 to 513)

Medium‐risk population

9 per 1000

64 per 1000
(8 to 513)

Febrile morbidity

Study population

RR 1.76
(0.87 to 3.55)

571
(4 studies)

⊕⊕⊕⊕
high

39 per 1000

69 per 1000
(34 to 138)

Medium‐risk population

39 per 1000

69 per 1000
(34 to 138)

Pelvic infection

Study population

RR 0.42
(0.11 to 1.62)

571
(4 studies)

⊕⊕⊕
moderate2

18 per 1000

8 per 1000
(2 to 29)

Medium‐risk population

19 per 1000

8 per 1000
(2 to 31)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RR: risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Wide confidence interval.
2Small number of events in the analysis.

Figuras y tablas -
Summary of findings for the main comparison. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for gynaecological malignancies
Comparison 1. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery Show forest plot

2

204

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.04, 13.35]

2 Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery Show forest plot

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

3.25 [1.26, 8.37]

3 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery Show forest plot

2

180

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.30, 1.71]

4 Short‐term lymphocyst formation: both asymptomatic and symptomatic at 12 weeks after surgery Show forest plot

1

83

Risk Ratio (M‐H, Fixed, 95% CI)

0.13 [0.01, 2.38]

5 Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery Show forest plot

1

232

Risk Ratio (M‐H, Fixed, 95% CI)

1.48 [0.89, 2.45]

6 Long‐term lymphocyst formation: symptomatic at 12 months after surgery Show forest plot

1

232

Risk Ratio (M‐H, Fixed, 95% CI)

7.12 [0.89, 56.97]

7 Febrile morbidity Show forest plot

4

571

Risk Ratio (M‐H, Fixed, 95% CI)

1.76 [0.87, 3.55]

8 Pelvic infection Show forest plot

4

571

Risk Ratio (M‐H, Fixed, 95% CI)

0.42 [0.11, 1.62]

9 Wound infection Show forest plot

2

334

Risk Ratio (M‐H, Fixed, 95% CI)

0.29 [0.07, 1.18]

10 Wound dehiscence Show forest plot

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

0.99 [0.14, 6.89]

11 Fistula Show forest plot

3

471

Risk Ratio (M‐H, Fixed, 95% CI)

1.24 [0.34, 4.57]

12 Bowel obstruction Show forest plot

2

334

Risk Ratio (M‐H, Fixed, 95% CI)

0.2 [0.01, 4.12]

13 Leg oedema Show forest plot

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

2.71 [0.75, 9.77]

14 Deep venous thrombosis Show forest plot

2

371

Risk Ratio (M‐H, Fixed, 95% CI)

2.02 [0.38, 10.84]

15 Symptomatic ascites Show forest plot

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.12, 3.92]

16 Blood transfusion Show forest plot

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.68, 1.21]

17 Duration of surgery (minute) Show forest plot

1

100

Mean Difference (IV, Fixed, 95% CI)

4.20 [‐15.35, 23.75]

18 Return of bowel sounds (day) Show forest plot

1

100

Mean Difference (IV, Fixed, 95% CI)

0.14 [‐0.11, 0.39]

19 Hospital stay (day) Show forest plot

2

200

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐0.34, 0.74]

Figuras y tablas -
Comparison 1. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy